Drug Profile
Regrelor
Alternative Names: INS 50589 Antiplatelet; INS 50589 Cardiovascular; INS-50589Latest Information Update: 16 Dec 2008
Price :
$50
*
At a glance
- Originator Inspire Pharmaceuticals
- Class Antiplatelets; Small molecules
- Mechanism of Action Purinergic P2 receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 16 Dec 2008 Discontinued - Phase-II for Thrombosis in USA (IV)
- 11 Aug 2006 Suspended - Phase-II for Thrombosis in USA (IV-infusion)
- 28 Apr 2006 Phase-II clinical trials in Thrombosis in USA (IV-infusion)